scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BBMT.2008.03.001 |
P698 | PubMed publication ID | 18489998 |
P50 | author | Koen van Besien | Q43263315 |
P2093 | author name string | Cara Rosenbaum | |
David Peace | |||
Elizabeth Rich | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 719-723 | |
P577 | publication date | 2008-06-01 | |
P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
P1476 | title | Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease | |
P478 | volume | 14 |
Q36941032 | A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation |
Q48318556 | Automated red blood cell exchange in preparation for filgrastim mobilization of autologous peripheral blood hematopoietic progenitor cells in a patient with sickle cell anemia. |
Q92615628 | Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates |
Q37354296 | Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? |
Q27001570 | Hematopoietic stem cell engineering at a crossroads |
Q35665207 | Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects |
Q64061469 | Management of Hodgkin Lymphoma in a Sickle Cell Patient: A Case Report |
Q41777376 | Pathophisiology of sickle cell disease and new drugs for the treatment |
Q50145999 | Plerixafor enables the safe, rapid, efficient mobilization of haematopoietic stem cells in sickle cell disease patients after exchange transfusion |
Q37417406 | Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia. |
Q38028432 | Stem cell transplantation for treatment of sickle cell disease: bone marrow versus cord blood transplants |
Search more.